Skip directly to content

statecampaign

Trump Tax Reform Ignores Worst Problem in Tax Code

Our comments on the much anticipated tax reform plan:

"Already, our loophole-ridden corporate tax code is rigged for big companies and their armies of tax lawyers. Not only does this plan do nothing about the worst part of our tax code -- that it rewards hiding profits offshore -- it makes it worse ... "

Now onto taxes ...

Now that the health care vote has been delayed (for now), it appears that tax reform will move to the top of the agenda.

Just like with health care reform, the details are being kept hidden for now. No matter what plans are put forward, you can be sure that we at Fair Share will:

6 ways the Senate Democrats' infrastructure plan will work better than President Trump's

The Trump White House previewed part of their infrastructure, and Senate Democrats have countered with a plan on its own.

While we don't know exactly what the administration is planning, during the campaign they offered an overview of a plan that focused on tax breaks for private developers. Over the last few days, a list of possible projects was leaked which appear to be at odds with that earlier overview.

Fair Share supports investing in infrastructure, prioritizing repair, maintenance, long-term sustainability and expanding access to economic opportunities.

Study: Offshore Corporate Cash Stockpile Up to $2.5 Trillion

73% of Fortune 500 Companies used tax havens in 2015, dodging $717.8 billion in federal taxes in the process.

A new report, "Offshore Shell Games," by the U.S. PIRG Education Fund, Citizens for Tax Justice and the Institute on Taxation and Economic Policy details how these companies hoard cash offshore. Collectively, multinationals reported booking $2.5 trillion offshore, with just 30 companies accounting for 66 percent of this total.

The cost to the tax payer is huge, with nearly $718 billion in dodged taxes.

There is a real cost to our communities when we allow a set of companies to play

We need to look into EpiPen

The makers of EpiPen testified in front of Congress -- and it was an epic fail.

They failed to justify their 500% price increase, their 600% increase in executive pay, or their tax-dodging move of corporate offices to the Netherlands.1

Join our campaign to tell the FTC to investigate Mylan for price-gouging and anti-competitive behavior.

Since acquiring the product in 2007, Mylan has raised the price of an EpiPen two-pack from a little over $90 to more than $600.2

Imagine you’re the parent of a child who suffers severe allergic reactions. You depend on the EpiPen to keep your child safe.

Pages